Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luspatercept + Thalidomide vs Luspatercept in Transfusion-dependent β-thalassemia
NCT07338344Phase 2Recruiting
- Sponsor
- Rongrong Liu
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in beta thalassemia, sponsored by Rongrong Liu. Started Feb 2026; status: recruiting.
02
Drugs
thalidomide
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT07338344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07338344.